COPENHAGEN (Reuters) -Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the ...

Popular drugs for weight loss are now being prescribed to kids as young as 12. It’s been nearly two years since the FDA approved their use in kids, but some are questioning if these drugs are safe for ...

Weight loss drugs Ozempic and Wegovy would no longer be covered by California’s health insurance for low-income people under ...

A recent study showed that well-known diabetes and weight loss drugs such as Ozempic and Wegovy do not raise the risk of ...

There are plenty of people taking Ozempic to lose weight, but Doctor Giles Yeo has explained the main problem people have ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a drug ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

The drug is set to be available on the NHS for weight loss soon, but one expert has flagged some potential risks that come with it.

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...